Erik R. Sampson

1.9k citations

28 papers · 1.5k indexed · 1 hit paper · h-index 18

Co-authors: Di Chen Michael J. Zuscik Randy N. Rosier Meina Wang Hongting Jin Regis J. O’Keefe Jia Li Hee‐Jeong Im
Topics: Osteoarthritis Treatment and Mechanisms (10 papers)TGF-β signaling in diseases (6 papers)Bone Metabolism and Diseases (5 papers)
Cited by: Rheumatology Cancer Research Pharmacology
Journals: Nature Journal of Biological Chemistry The Journal of Immunology
Partner nations: United States China France

In The Last Decade

Erik R. Sampson

27 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

MMP13 is a critical target gene during the progression of osteoarthritis

2013 421 citations Meina Wang, Erik R. Sampson et al. Arthritis Research & Therapy profile →

Peers

Countries citing papers authored by Erik R. Sampson

Since Specialization

Citations

This map shows the geographic impact of Erik R. Sampson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik R. Sampson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik R. Sampson more than expected).

Fields of papers citing papers by Erik R. Sampson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik R. Sampson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik R. Sampson. The network helps show where Erik R. Sampson may publish in the future.

Co-authorship network of co-authors of Erik R. Sampson

This figure shows the co-authorship network connecting the top 25 collaborators of Erik R. Sampson. A scholar is included among the top collaborators of Erik R. Sampson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik R. Sampson. Erik R. Sampson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	HLA-Restriction of Human Treg Cells Is Not Required for Therapeutic Efficacy of Low-Dose IL-2 in Humanized Mice 2021 ·Frontiers in Immunology ·Rajeev K. Tyagi,Justin Jacobse,Jing Li,Margaret M. Allaman,Kevin L. Otipoby,Erik R. Sampson,Keith T. Wilson,Jeremy A. Goettel	13
2	Generation of PT101, a highly selective IL-2 mutein for treatment of autoimmune diseases 2021 ·The Journal of Immunology ·Jyothsna Visweswaraiah,Erik R. Sampson,(unknown),(unknown),(unknown),Katalin Kis‐Tóth,Kevin L. Otipoby,John S. Sundy,(unknown),Joanne L. Viney	3
3	Surgical Induction of Posttraumatic Osteoarthritis in the Mouse 2014 ·Methods in molecular biology ·Daisuke Hamada,Erik R. Sampson,Robert Maynard,Michael J. Zuscik	15
4	MMP13 is a critical target gene during the progression of osteoarthritisbreakdown → 2013 ·Arthritis Research & Therapy ·Meina Wang,Erik R. Sampson,Hongting Jin,Jia Li,(unknown),Hee‐Jeong Im,Di Chen	421
5	Ski inhibits TGF‐β/phospho‐Smad3 signaling and accelerates hypertrophic differentiation in chondrocytes 2012 ·Journal of Cellular Biochemistry ·(unknown),Erik R. Sampson,Robert Maynard,Regis J. O’Keefe,Di Chen,Hicham Drissi,Randy N. Rosier,Matthew J. Hilton,Michael J. Zuscik	34
6	Gene signature critical to cancer phenotype as a paradigm for anticancer drug discovery 2012 ·Oncogene ·Erik R. Sampson,Helene R. McMurray,Duane C. Hassane,Laurel Newman,Peter Salzman,Craig T. Jordan,Hartmut Land	7
7	Conditional activation of β‐catenin signaling in mice leads to severe defects in intervertebral disc tissue 2012 ·Arthritis & Rheumatism ·Meina Wang,Dezhi Tang,Bing Shu,Baoli Wang,Hongting Jin,Suyang Hao,Karen Dresser,Jie Shen,Hee‐Jeong Im,Erik R. Sampson,Paul T. Rubery,Michael J. Zuscik,Edward M. Schwarz,Regis J. O’Keefe,Yongjun Wang,Di Chen	85
8	Establishment of an index with increased sensitivity for assessing murine arthritis 2011 ·Journal of Orthopaedic Research® ·Erik R. Sampson,Christopher A. Beck,John Ketz,(unknown),Matthew J. Hilton,Hani A. Awad,Edward M. Schwarz,Di Chen,Regis J. O’Keefe,Randy N. Rosier,Michael J. Zuscik	41
9	Unique angiogenic and vasculogenic properties of renal cell carcinoma in a xenograft model of bone metastasis are associated with high levels of vegf‐a and decreased ang‐1 expression 2011 ·Journal of Orthopaedic Research® ·Chao Xie,Edward M. Schwarz,Erik R. Sampson,(unknown),Dan Li,Regis J. O’Keefe,Wakenda K. Tyler	19
10	Teriparatide as a Chondroregenerative Therapy for Injury-Induced Osteoarthritis 2011 ·Science Translational Medicine ·Erik R. Sampson,Matthew J. Hilton,Ye Tian,Di Chen,Edward M. Schwarz,Robert A. Mooney,Susan V. Bukata,Regis J. O’Keefe,Hani A. Awad,J. Edward Puzas,Randy N. Rosier,Michael J. Zuscik	143
11	The orally bioavailable met inhibitor PF-2341066 inhibits osteosarcoma growth and osteolysis/matrix production in a xenograft model 2011 ·Journal of Bone and Mineral Research ·Erik R. Sampson,(unknown),Aimee M. Morris,Chao Xie,Edward M. Schwarz,Regis J. O’Keefe,Randy N. Rosier	42
12	Aberrant hypertrophy in Smad3‐deficient murine chondrocytes is rescued by restoring transforming growth factor β–activated kinase 1/activating transcription factor 2 signaling: A potential clinical implication for osteoarthritis 2010 ·Arthritis & Rheumatism ·Tian‐Fang Li,Lin Gao,Tzong‐Jen Sheu,Erik R. Sampson,Lisa M. Flick,Yrjö T. Konttinen,Di Chen,Edward M. Schwarz,Michael J. Zuscik,Jennifer H. Jonason,Regis J. O’Keefe	43
13	The histone deacetylase inhibitor vorinostat selectively sensitizes fibrosarcoma cells to chemotherapy 2010 ·Journal of Orthopaedic Research® ·Erik R. Sampson,(unknown),Edward M. Schwarz,Regis J. O’Keefe,Randy N. Rosier	23
14	Smurf2 induces degradation of GSK-3β and upregulates β-catenin in chondrocytes: A potential mechanism for Smurf2-induced degeneration of articular cartilage 2009 ·Experimental Cell Research ·Qiuqian Wu,Jason H. Huang,Erik R. Sampson,(unknown),Michael J. Zuscik,Regis J. O’Keefe,Di Chen,Randy N. Rosier	48
15	Induction of an osteoarthritis‐like phenotype and degradation of phosphorylated Smad3 by Smurf2 in transgenic mice 2008 ·Arthritis & Rheumatism ·Qiuqian Wu,(unknown),Erik R. Sampson,Di Chen,Hani A. Awad,(unknown),J. Edward Puzas,Hicham Drissi,Edward M. Schwarz,Regis J. O’Keefe,Michael J. Zuscik,Randy N. Rosier	102
16	Synergistic response to oncogenic mutations defines gene class critical to cancer phenotype 2008 ·Nature ·Helene R. McMurray,Erik R. Sampson,(unknown),Conan G. Kinsey,Laurel Newman,Bradley Smith,(unknown),Lev B. Klebanov,Peter Salzman,(unknown),Hartmut Land	122
17	Functional Domain and Motif Analyses of Androgen Receptor Coregulator ARA70 and Its Differential Expression in Prostate Cancer 2004 ·Journal of Biological Chemistry ·Yueh‐Chiang Hu,Shuyuan Yeh,Shauh-Der Yeh,Erik R. Sampson,Jiaoti Huang,Peng Li,Cheng-Lung Hsu,Huei‐Ju Ting,Hui‐Kuan Lin,Liang Wang,Eungseok Kim,Jing Ni,Chawnshang Chang	81
18	Suppression of Androgen Receptor Transactivation by Pyk2 via Interaction and Phosphorylation of the ARA55 Coregulator 2002 ·Journal of Biological Chemistry ·Xin Wang,Yue Yang,(unknown),Erik R. Sampson,Cheng-Lung Hsu,(unknown),Shuyuan Yeh,Guan Wu,Yinglu Guo,Chawnshang Chang	47
19	Mutations in the Helix 3 Region of the Androgen Receptor Abrogate ARA70 Promotion of 17β-Estradiol-induced Androgen Receptor Transactivation 2002 ·Journal of Biological Chemistry ·Tin Htwe Thin,Eungseok Kim,Shuyuan Yeh,Erik R. Sampson,Yei‐Tsung Chen,Loretta L. Collins,Ravi Basavappa,Chawnshang Chang	19
20	Assignment<footref rid="foot01"><sup>1</sup></footref> of KCNK6 encoding the human weak inward rectifier potassium channel TWIK-2 to chromosome band 19q13.1 by radiation hybrid mapping 1999 ·Cytogenetic and Genome Research ·Andrew T. Gray,Christoph Kindler,Erik R. Sampson,C. Spencer Yost	6

About Erik R. Sampson

Erik R. Sampson is a scholar working on Rheumatology, Immunology and Molecular Biology, having authored 28 papers that have together received 1.5k indexed citations. Recurring topics across this work include Osteoarthritis Treatment and Mechanisms (10 papers), TGF-β signaling in diseases (6 papers) and Bone Metabolism and Diseases (5 papers). The work is most often cited by research in Rheumatology (749 citations), Cancer Research (268 citations) and Pharmacology (293 citations). Erik R. Sampson has collaborated with scholars based in United States, China and France. Frequent co-authors include Di Chen, Michael J. Zuscik, Randy N. Rosier, Meina Wang, Hongting Jin, Regis J. O’Keefe, Jia Li, Hee‐Jeong Im, Edward M. Schwarz and Robert A. Mooney. Their work appears in journals such as Nature, Journal of Biological Chemistry and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact